Matrix metalloproteinase-2: the forgotten enzyme in aneurysm pathogenesis

Area of Science:

• Vascular biology
• Biochemistry
• Pathogenesis of aortic aneurysms

Background:

• Abdominal aortic aneurysm (AAA) pathogenesis involves proteolysis and inflammation cycles.
• The initiating events of AAA formation remain largely unknown.
• Elastolysis is an early histological sign in aneurysm development.

Purpose of the Study:

• To investigate the potential role of matrix metalloproteinase-2 (MMP-2) as an initial catalyst in AAA pathogenesis.
• To review existing literature and present new experimental data on MMP-2's role.

Main Methods:

• Literature review focusing on MMP-2 and AAA initiation.
• In vivo experimental models of AAA.
• In vitro studies using cells derived from aneurysms.

Main Results:

• Matrix metalloproteinase-2 (MMP-2) is identified as the dominant gelatinase differentially expressed in AAA tissues and cells.
• Experimental data supports MMP-2's involvement in the early stages of AAA development.
• MMP-2's role as an aneurysmal initiator is supported by both in vivo and in vitro findings.

Conclusions:

• Matrix metalloproteinase-2 (MMP-2) is a strong candidate for initiating abdominal aortic aneurysm (AAA) formation.
• Further research into MMP-2's role could lead to novel therapeutic strategies for AAA.
• Understanding early AAA pathogenesis is crucial for effective intervention.